Clinical Translation of Stem Cell Therapies: A Bridgeable Gap

被引：40
作者：
Cuende, Natividad [1 ]
Izeta, Ander [2 ]
机构：
[1] Andalusian Initiat Adv Therapies, Seville 41101, Spain
[2] Hosp Donostia, Inst Biodonostia, San Sebastian 20014, Spain
来源：
CELL STEM CELL | 2010年 / 6卷 / 06期
关键词：
D O I：
10.1016/j.stem.2010.05.005
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Stem cell scientists trying to reach patients often lack the multidisciplinary skills needed to overcome complex regulatory barriers and may feel deterred from pursuing clinical implementation. In order to help bridge this gap, we offer a European perspective based on our hands-on experience at the Andalusian Initiative for Advanced Therapies.
引用
收藏
页码：508 / 512
页数：5
相关论文
共 11 条
  • [1] Isolation and Production of Cells Suitable for Human Therapy: Challenges Ahead
    Ahrlund-Richter, Lars
    De Luca, Michele
    Marshak, Daniel R.
    Munsie, Megan
    Veiga, Anna
    Rao, Mahendra
    [J]. CELL STEM CELL, 2009, 4 (01) : 20 - 26
  • [2] Aiuti Alessandro, 2009, Hematology Am Soc Hematol Educ Program, P682, DOI 10.1182/asheducation-2009.1.682
  • [3] Stem cells: roadmap to the clinic
    Daley, George Q.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (01) : 8 - 10
  • [4] Stem cell therapy delivery: treading the regulatory tightrope
    Daniels, Julie T.
    Secker, Genevieve A.
    Shortt, Alex J.
    Tuft, Stephen J.
    Seetharaman, Sbankar
    [J]. REGENERATIVE MEDICINE, 2006, 1 (05) : 715 - 719
  • [5] New ISSCR Guidelines Underscore Major Principles for Responsible Translational Stem Cell Research
    Hyun, Insoo
    Lindvall, Olle
    Ahrlund-Richter, Lars
    Cattaneo, Elena
    Cavazzana-Calvo, Marina
    Cossu, Giulio
    De Luca, Michele
    Fox, Ira J.
    Gerstle, Claude
    Goldstein, Robert A.
    Hermeren, Goran
    High, Katherine A.
    Kim, Hyun Ok
    Lee, Hin Peng
    Levy-Lahad, Ephrat
    Li, Lingsong
    Lo, Bernard
    Marshak, Daniel R.
    McNab, Angela
    Munsie, Megan
    Nakauchi, Hiromitsu
    Rao, Mahendra
    Rooke, Heather M.
    Valles, Carlos Simon
    Srivastava, Alok
    Sugarman, Jeremy
    Taylor, Patrick L.
    Veiga, Anna
    Wong, Adrianne L.
    Zoloth, Laurie
    Daley, George Q.
    [J]. CELL STEM CELL, 2008, 3 (06) : 607 - 609
  • [6] Can the pharmaceutical industry reduce attrition rates?
    Kola, I
    Landis, J
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (08) : 711 - 715
  • [7] Great expectations: Private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics
    Lysaght, Michael J.
    Jaklenec, Ana
    Deweerd, Elizabeth
    [J]. TISSUE ENGINEERING PART A, 2008, 14 (02) : 305 - U57
  • [8] Pharma's Developing Interest in Stem Cells
    McKernan, Ruth
    McNeish, John
    Smith, Devyn
    [J]. CELL STEM CELL, 2010, 6 (06) : 517 - 520
  • [9] Developing a Case Study Model for Successful Translation of Stem Cell Therapies
    Trounson, Alan
    Baum, Elona
    Gibbons, Don
    Tekamp-Olson, Patricia
    [J]. CELL STEM CELL, 2010, 6 (06) : 513 - 516
  • [10] ELIXIRS, DILUENTS, AND THE PASSAGE OF THE 1938 FEDERAL FOOD, DRUG AND COSMETIC ACT
    WAX, PM
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 122 (06) : 456 - 461
12